Pa. Justices Reject Wyeth's Appeal Of $11M Prempro Suit

Law360, Philadelphia (October 17, 2013, 5:06 PM ET) -- The Pennsylvania Supreme Court on Wednesday shot down an appeal by Pfizer Inc. unit Wyeth Pharmaceuticals Inc. over $11.3 million in compensatory and punitive damages awarded to a woman who alleged that she developed breast cancer after taking the menopause drug Prempro.

The justices rejected a petition by Wyeth asking them to reconsider a January 2010 decision by the state's Superior Court agreeing that the drugmaker systematically ignored warning signs that the hormone replacement drugs Prempro and Provera were linked to breast cancer.

The justices did...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers